Other NK1R inhibitors, such as orvepitant and tradipitant, have been tested in clinical trials for the pruritus associated with epidermal growth factor receptor inhibitor and atopic dermatitis, respectively; however, neither of them demonstrated significant improvement of pruritus over placebo.105, 106. Here, TACR1 is linked to Pruritus.